187 related articles for article (PubMed ID: 1848685)
1. Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virus.
Acha-Orbea H; Shakhov AN; Scarpellino L; Kolb E; Müller V; Vessaz-Shaw A; Fuchs R; Blöchlinger K; Rollini P; Billotte J
Nature; 1991 Mar; 350(6315):207-11. PubMed ID: 1848685
[TBL] [Abstract][Full Text] [Related]
2. Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes.
Dyson PJ; Knight AM; Fairchild S; Simpson E; Tomonari K
Nature; 1991 Feb; 349(6309):531-2. PubMed ID: 1846950
[TBL] [Abstract][Full Text] [Related]
3. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus.
Choi Y; Kappler JW; Marrack P
Nature; 1991 Mar; 350(6315):203-7. PubMed ID: 1706480
[TBL] [Abstract][Full Text] [Related]
4. Identification of an endogenous mammary tumor virus involved in the clonal deletion of V beta 2 T cells.
Jouvin-Marche E; Marche PN; Six A; Liebe-Gris C; Voegtle D; Cazenave PA
Eur J Immunol; 1993 Nov; 23(11):2758-64. PubMed ID: 8223851
[TBL] [Abstract][Full Text] [Related]
5. Clonal deletion of V beta 17 T cells in mice from natural populations.
Jouvin-Marche E; Marche PN; Cazenave PA
Semin Immunol; 1992 Oct; 4(5):305-12. PubMed ID: 1362500
[TBL] [Abstract][Full Text] [Related]
6. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice.
Frankel WN; Rudy C; Coffin JM; Huber BT
Nature; 1991 Feb; 349(6309):526-8. PubMed ID: 1846948
[TBL] [Abstract][Full Text] [Related]
7. Why is clonal deletion of neonatal thymocytes defective?
Signorelli K; Benoist C; Mathis D
Eur J Immunol; 1992 Oct; 22(10):2487-93. PubMed ID: 1327799
[TBL] [Abstract][Full Text] [Related]
8. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages.
Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM
J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568
[TBL] [Abstract][Full Text] [Related]
9. Delay in expression of a mammary tumor provirus is responsible for defective clonal deletion during postnatal period.
Niimi N; Wajjwalku W; Ando Y; Tomida S; Takeuchi M; Ueda M; Kaneda T; Yoshikai Y
Eur J Immunol; 1994 Feb; 24(2):488-91. PubMed ID: 8299700
[TBL] [Abstract][Full Text] [Related]
10. MHC class II A alpha and E alpha molecules determine the clonal deletion of V beta 6+ T cells. Studies with recombinant and transgenic mice.
Anderson GD; Banerjee S; David CS
J Immunol; 1989 Dec; 143(11):3757-61. PubMed ID: 2531186
[TBL] [Abstract][Full Text] [Related]
11. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7.
Beutner U; Frankel WN; Cote MS; Coffin JM; Huber BT
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5432-6. PubMed ID: 1319061
[TBL] [Abstract][Full Text] [Related]
12. A kinetic study on the deletion of thymic, peripheral, and gut-associated V beta 6+ T cells in an Mls-1b BALB/c colony infected with an exogenous mouse mammary tumor virus.
Tucek CL; Desaymard C; Papiernik M
J Immunol; 1993 Jul; 151(2):759-66. PubMed ID: 8101538
[TBL] [Abstract][Full Text] [Related]
13. I-J revisited: is the I-J genetic restriction in downregulation due to an endogenous superantigen analogous to mammary tumour virus (Mtv)-encoded endogenous superantigen?
Asherson GL; Dieli F; Tomonari K
Folia Biol (Praha); 1994; 40(6):341-7. PubMed ID: 7589693
[TBL] [Abstract][Full Text] [Related]
14. An endogenous retrovirus mediating deletion of alpha beta T cells?
Woodland DL; Happ MP; Gollob KJ; Palmer E
Nature; 1991 Feb; 349(6309):529-30. PubMed ID: 1846949
[TBL] [Abstract][Full Text] [Related]
15. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
[TBL] [Abstract][Full Text] [Related]
16. Thymic deletion of V beta 11+, V beta 5+ T cells in H-2E negative, HLA-DQ beta+ single transgenic mice.
Zhou P; Anderson GD; Savarirayan S; Inoko H; David CS
J Immunol; 1991 Feb; 146(3):854-9. PubMed ID: 1899097
[TBL] [Abstract][Full Text] [Related]
17. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
Hodes RJ; Novick MB; Palmer LD; Knepper JE
J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
[TBL] [Abstract][Full Text] [Related]
18. A role for clonal inactivation in T cell tolerance to Mls-1a.
Blackman MA; Burgert HG; Woodland DL; Palmer E; Kappler JW; Marrack P
Nature; 1990 Jun; 345(6275):540-2. PubMed ID: 1971916
[TBL] [Abstract][Full Text] [Related]
19. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection.
Chervonsky AV; Golovkina TV; Ross SR; Janeway CA
J Immunol; 1995 Dec; 155(11):5115-23. PubMed ID: 7594520
[TBL] [Abstract][Full Text] [Related]
20. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
